Celularity Inc. develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.
Market Cap | 139.938 Million | Shares Outstanding | 145.013 Million | Avg 30-day Volume | 798.654 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -2.52 |
Price to Revenue | 0.0 | Debt to Equity | 0.396 | EBITDA | -196.942 Million |
Price to Book Value | 9.0938 | Operating Margin | 0.0 | Enterprise Value | 825.627 Million |
Current Ratio | EPS Growth | 0 | Quick Ratio | ||
1 Yr BETA | 1.2924 | 52-week High/Low | 13.19 / 0.83 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -103.6715 | Altman Z-Score | Free Cash Flow to Firm | 0 | |
Earnings Report | 2023-03-30 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
HARIRI ROBERT J CHIEF EXECUTIVE OFFICER |
|
8,074,996 | 2022-11-30 | 5 |
FLETCHER KYLE GENERAL COUNSEL |
|
34,170 | 2022-11-16 | 3 |
KILCOYNE ADRIAN SEE REMARKS |
|
66,226 | 2022-10-03 | 2 |
|
804,739 | 2022-08-26 | 2 | |
|
1,050,000 | 2022-08-16 | 2 | |
|
90,297 | 2022-07-13 | 1 | |
|
90,297 | 2022-07-13 | 1 | |
|
90,297 | 2022-07-13 | 1 | |
|
90,297 | 2022-07-13 | 1 | |
|
190,297 | 2022-07-13 | 1 | |
|
90,297 | 2022-07-13 | 3 | |
GLOVER BRADLEY CHIEF TECHNOLOGY OFFICER |
|
71,291 | 2022-07-13 | 2 |
JONES ANNE CHIEF BUSINESS OFFICER |
|
61,558 | 2022-07-13 | 2 |
HAINES JOHN R SEE REMARKS |
|
258,018 | 2022-04-13 | 1 |
DUNN KEARY SEE REMARKS |
|
64,505 | 2022-04-13 | 1 |
BEERS DAVID C CHIEF FINANCIAL OFFICER |
|
161,262 | 2022-04-13 | 1 |
BRIGIDO STEPHEN PRES, FUNCTIONAL REGENERATION |
|
129,010 | 2022-04-13 | 1 |
|
15,281,389 | 2022-03-01 | 1 | |
PECORA ANDREW L PRESIDENT |
|
0 | 2021-09-15 | 0 |
MIRAKHUR BELOO EVP, CLINICAL DEVELOPMENT |
|
125,000 | 2021-09-13 | 0 |
|
56,053 | 2021-09-09 | 0 | |
|
20,422,124 | 2021-07-16 | 0 | |
|
8,640,695 | 2021-07-16 | 1 | |
|
100,000 | 2021-07-16 | 0 | |
|
30,062,778 | 2021-07-16 | 0 | |
|
0 | 2019-05-20 | 0 | |
KELLETT ANDREA J. CHIEF FINANCIAL OFFICER |
|
0 | 2019-05-20 | 0 |
MASELLI MICHAEL G VICE PRESIDENT OF ACQUISITIONS |
|
0 | 2019-05-20 | 0 |
|
0 | 2019-05-20 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
CELULARITY INC CELU | 2023-02-06 15:15:03 UTC | -9.2334 | 13.8034 | 500000 |
CELULARITY INC CELU | 2023-02-06 14:45:04 UTC | -9.2619 | 13.8319 | 500000 |
CELULARITY INC CELU | 2023-02-06 14:15:04 UTC | -9.2619 | 13.8319 | 500000 |
CELULARITY INC CELU | 2023-02-06 13:45:03 UTC | -9.2619 | 13.8319 | 350000 |
CELULARITY INC CELU | 2023-02-06 13:15:03 UTC | -9.2619 | 13.8319 | 300000 |
CELULARITY INC CELU | 2023-02-06 12:45:03 UTC | -9.2619 | 13.8319 | 300000 |
CELULARITY INC CELU | 2023-02-03 22:15:03 UTC | -9.2619 | 13.8319 | 200000 |
CELULARITY INC CELU | 2023-02-03 21:45:03 UTC | -9.3864 | 13.9564 | 200000 |
CELULARITY INC CELU | 2023-02-03 21:15:03 UTC | -9.3864 | 13.9564 | 200000 |
CELULARITY INC CELU | 2023-02-03 20:45:06 UTC | -9.3864 | 13.9564 | 200000 |
CELULARITY INC CELU | 2023-02-03 20:15:04 UTC | -9.3864 | 13.9564 | 200000 |
CELULARITY INC CELU | 2023-02-03 19:45:03 UTC | -9.3864 | 13.9564 | 200000 |
CELULARITY INC CELU | 2023-02-03 19:15:04 UTC | -9.3864 | 13.9564 | 200000 |
CELULARITY INC CELU | 2023-02-03 18:45:03 UTC | -9.3864 | 13.9564 | 500000 |
CELULARITY INC CELU | 2023-02-03 18:15:03 UTC | -9.3864 | 13.9564 | 500000 |
CELULARITY INC CELU | 2023-02-03 17:45:03 UTC | -9.3864 | 13.9564 | 500000 |
CELULARITY INC CELU | 2023-02-03 17:15:04 UTC | -9.3864 | 13.9564 | 500000 |
CELULARITY INC CELU | 2023-02-03 16:45:04 UTC | -9.3864 | 13.9564 | 500000 |
CELULARITY INC CELU | 2023-02-03 16:15:03 UTC | -9.3864 | 13.9564 | 500000 |
CELULARITY INC CELU | 2023-02-03 15:45:03 UTC | -9.3864 | 13.9564 | 500000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|